A potential COVID-19 vaccine, delivered by microscopic needles, produces antibodies specific to the virus when tested in mice. This is the first peer-reviewed paper describing a COVID-19 vaccine candidate. The next step is a human clinical trial.
Developed by researchers at the Butantan Institute (Brazil) and Boston Children's Hospital, part of the Harvard Medical School (USA), the innovation is capable of providing protection against all serotypes of the bacterium Streptococcus pneumoniae.
During the 2016 election cycle, politically polarizing tweets by Russian trolls about vaccination included pro- and anti-vaccination messages targeted at people with specific political inclinations through a nine different fake persona types, according to a new study. Now, as the nation deals with the coronavirus pandemic, the researchers raise concerns that such polarization potentially affects crisis communications and creates tensions, mistrust, and a lack of intention to comply with government health directives.
UC Davis Health physicians and medical staff detail the diagnosis and treatment for first known case of community transmission of COVID-19 in the US. The case reveals how the patient's symptoms matched -- and sometimes varied from -- published studies of COVID-19 infection at the time.
New 'CALM' model on passenger movement developed using Frontera supercomputer.
Identifying interventions that improve vaccine efficacy in older persons is vital to deliver healthy ageing for an ageing population. Immunologists at the Babraham Institute, Cambridge, UK, have identified a route for counteracting the age-related loss of two key immune cell types by using genital wart cream to boost immune response to vaccination in aged mice. After this validation in mice, the findings offer an attractive intervention to tailor the make-up of vaccines for older people.
COVID-19 can have fatal consequences for people with underlying cardiovascular disease and cause cardiac injury even in patients without underlying heart conditions, according to a review published today in JAMA Cardiology by experts at The University of Texas Health Science Center at Houston (UTHealth).
In response to the rapid spread of the COVID-19 pandemic, an authoritative global scientific journal, aptly named Viruses, published a fundamental review of problems related to identifying and studying emerging pathogens, such as the notorious coronavirus.
New research reveals rising rates of liver cancer around the world, despite advances aimed at preventing the disease. The findings are published early online in CANCER, a peer-reviewed journal of the American Cancer Society (ACS).
In the 1960s, public health officials led the US and worldwide efforts that resulted in smallpox becoming the first human disease ever eradicated from the face of the earth. Researchers say appropriate concerns and not fear should play a major role in the emerging coronavirus pandemic, and public health efforts should focus on public health issues, not political or economic considerations.